Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.44 USD | -1.88% | -0.10% | +25.63% |
Mar. 12 | HC Wainwright Adjusts IGM Biosciences Price Target to $12 From $7, Maintains Neutral Rating | MT |
Mar. 07 | Earnings Flash (IGMS) IGM BIOSCIENCES Reports Q4 Revenue $651,000 | MT |
Evolution of the average Target Price on IGM Biosciences, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering IGM Biosciences, Inc.
HC Wainwright | |
RBC Capital Markets | |
BofA Securities | |
Wedbush | |
Morgan Stanley | |
Stifel Nicolaus | |
JPMorgan Chase | |
Truist Securities | |
Jefferies & Co. | |
Baird | |
Guggenheim |
EPS Revisions
- Stock
- Equities
- Stock IGM Biosciences, Inc. - Nasdaq
- Consensus IGM Biosciences, Inc.